dupilumab 300 mg, JNJ-95475939 clinical trials

A study of JNJ-95475939 in the treatment of participants with moderate to severe atopic dermatitis

This study is testing a new medicine, JNJ-95475939, for moderate to severe eczema (atopic dermatitis). Researchers want to see how well it works and if it's safe compared to a dummy treatment and an existing medicine. It involves adults aged 18 and over.